{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:32:39Z","timestamp":1772854359713,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106262\/Z\/14\/Z"],"award-info":[{"award-number":["106262\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106263\/Z\/14\/Z"],"award-info":[{"award-number":["106263\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["MRC_MC_UU_12012\/3"],"award-info":[{"award-number":["MRC_MC_UU_12012\/3"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bcp.2020.114216","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T02:31:49Z","timestamp":1599791509000},"page":"114216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic \u03b1-cell transdifferentiation"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-5083","authenticated-orcid":false,"given":"Dipak","family":"Sarnobat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-7863","authenticated-orcid":false,"given":"Charlotte R.","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-4050","authenticated-orcid":false,"given":"Neil","family":"Tanday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-6377","authenticated-orcid":false,"given":"Frank","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-2898","authenticated-orcid":false,"given":"Fiona M.","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-7943","authenticated-orcid":false,"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-176X","authenticated-orcid":false,"given":"Andrei I.","family":"Tarasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/dmrr.2608","article-title":"Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL\/KsJ db\/db mice with degenerative diabetes","volume":"31","author":"Moffett","year":"2015","journal-title":"Diabetes\/Metabolism Res. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2020.114216_b0010","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/MPA.0000000000000645","article-title":"Molecular mechanisms of toxicity and cell damage by chemicals in a human pancreatic beta cell line, 1.1 B4","volume":"45","author":"Vasu","year":"2016","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.bcp.2020.114216_b0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yexcr.2015.05.022","article-title":"Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity","volume":"336","author":"Vasu","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.114216_b0020","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1530\/JME-14-0290","article-title":"The role of transcription factors in the transdifferentiation of pancreatic islet cells","volume":"54","author":"van der Meulen","year":"2015","journal-title":"J. Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114216_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.stem.2014.11.001","article-title":"Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease","volume":"16","author":"Puri","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"7292","key":"10.1016\/j.bcp.2020.114216_b0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic \u03b1-cells to \u03b2-cells after extreme \u03b2-cell loss","volume":"464","author":"Thorel","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/19382014.2018.1472839","article-title":"Insulin acts as a repressive factor to inhibit the ability of PAR2 to induce islet cell transdifferentiation","volume":"10","author":"Lee","year":"2018","journal-title":"Islets"},{"issue":"7523","key":"10.1016\/j.bcp.2020.114216_b0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13633","article-title":"Diabetes recovery by age-dependent conversion of pancreatic \u03b4-cells into insulin producers","volume":"514","author":"Chera","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.devcel.2009.11.003","article-title":"Pancreatic exocrine duct cells give rise to insulin-producing \u03b2 cells during embryogenesis but not after birth","volume":"17","author":"Solar","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2020.114216_b0050","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/srep11703","article-title":"Beta-cell regeneration from vimentin+\/MafB+ cells after STZ-induced extreme beta-cell ablation","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.beem.2015.10.002","article-title":"Evolving function and potential of pancreatic alpha cells","volume":"29","author":"Stanojevic","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2009.05.035","article-title":"The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into \u03b1 and subsequently \u03b2 cells","volume":"138","author":"Collombat","year":"2009","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.bcp.2020.114216_b0065","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1101\/gad.16875711","article-title":"Context-specific \u03b1-to-\u03b2-cell reprogramming by forced Pdx1 expression","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066214","article-title":"Pancreatic \u03b1-cell specific deletion of mouse Arx leads to \u03b1-cell identity loss","volume":"8","author":"Wilcox","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0075","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2010.01.046","article-title":"\u03b1 Cell\u2013Specific Men1 Ablation Triggers the Transdifferentiation of Glucagon-Expressing Cells and Insulinoma Development","volume":"138","author":"Lu","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cmet.2018.07.002","article-title":"GABA and artesunate do not induce pancreatic \u03b1-to-\u03b2 cell transdifferentiation in vivo","volume":"28","author":"Ackermann","year":"2018","journal-title":"Cell Metab."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.114216_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2016.11.002","article-title":"Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis","volume":"168","author":"Ben-Othman","year":"2017","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.114216_b0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","article-title":"Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2020.114216_b0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2006-0007","article-title":"\u03b1-Cells of the endocrine pancreas: 35 years of research but the enigma remains","volume":"28","author":"Gromada","year":"2007","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096863","article-title":"Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy","volume":"9","author":"Moffett","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101005","article-title":"Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress","volume":"9","author":"Vasu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2020.114216_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2583047","article-title":"A New Way for Beta Cell Neogenesis: Transdifferentiation from Alpha Cells Induced by Glucagon-Like Peptide 1","volume":"2019","author":"Zhang","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3132\/dvdr.2006.024","article-title":"Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes","volume":"3","author":"Green","year":"2006","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-17-0263","article-title":"Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice","volume":"234","author":"Millar","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2020.114216_b0125","series-title":"SGLT2 inhibitors and protection against pancreatic beta cell failure","author":"Asahara","year":"2019"},{"key":"10.1016\/j.bcp.2020.114216_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2018.10.009","article-title":"SGLT1 in pancreatic \u03b1 cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels","volume":"19","author":"Suga","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2020.114216_b0135","unstructured":"J.R. Campbell, A. Martchenko, M.E. Sweeney, F. Michael, A. Psichas, F.M. Gribble, F. Reimann, P.L. Brubaker, Essential role of Munc18-1 in the regulation of glucagon-like peptide-1 secretion, https:\/\/tspace.library.utoronto.ca\/handle\/1807\/98201."},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.bcp.2020.114216_b0145","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2337\/diab.45.11.1489","article-title":"Glycation of insulin in the islets of Langerhans of normal and diabetic animals","volume":"45","author":"Abdel-Wahab","year":"1996","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.bcp.2020.114216_b0150","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/gt.2013.33","article-title":"Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice","volume":"20","author":"Vasu","year":"2013","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/db09-1177","article-title":"Unique arrangement of \u03b1-and \u03b2-cells in human islets of Langerhans","volume":"59","author":"Bosco","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2020.114216_b0160","unstructured":"R Development Core Team., R: A Language and Environment for Statistical Computing. *https:\/\/www.R-project.org\/*, 2019)."},{"issue":"2","key":"10.1016\/j.bcp.2020.114216_b0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<176::AID-PATH433>3.0.CO;2-8","article-title":"Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model","volume":"178","author":"O'Brien","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2020.114216_b0170","article-title":"Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2; ROSA26-eYFP mice","volume":"170205","author":"Sarnobat","year":"2019","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis","year":"2010","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.bcp.2020.114216_b0180","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-017-4315-2","article-title":"The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice","volume":"60","author":"\u00d8rgaard","year":"2017","journal-title":"Diabetologia"},{"issue":"18","key":"10.1016\/j.bcp.2020.114216_b0185","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1039\/C8LC00417J","article-title":"Monitoring real-time hormone release kinetics via high-content 3-D imaging of compensatory endocytosis","volume":"18","author":"Tarasov","year":"2018","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0190","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/db17-1102","article-title":"Adrenaline Stimulates Glucagon Secretion by Tpc2-Dependent Ca(2+) Mobilization From Acidic Stores in Pancreatic alpha-Cells","volume":"67","author":"Hamilton","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0195","first-page":"1236","article-title":"Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced \u03b2-cell damage and pancreatic Glp-1 gene therapy","volume":"6","author":"Tonne","year":"2013","journal-title":"Disease Models Mech."},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jdi.12945","article-title":"Early administration of dapagliflozin preserves pancreatic \u03b2-cell mass through a legacy effect in a mouse model of type 2 diabetes","volume":"10","author":"Kanno","year":"2019","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.bcp.2020.114216_b0205","article-title":"Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta-to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance","volume":"114009","author":"Tanday","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114216_b0210","article-title":"Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice","volume":"154324","author":"Wei","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2020.114216_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0094","article-title":"Processing of proglucagon to GLP-1 in pancreatic a-cells: is this a paracrine mechanism enabling GLP-1 to act on b-cells","volume":"211","author":"Whalley","year":"2011","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114216_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09898-4","article-title":"GLP-1\/Exendin-4 induces \u03b2-cell proliferation via the epidermal growth factor receptor","volume":"7","author":"Fusco","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2020.114216_b0225","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00125-010-1817-6","article-title":"Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes","volume":"53","author":"Willcox","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.bcp.2020.114216_b0230","doi-asserted-by":"crossref","first-page":"bqaa011","DOI":"10.1210\/endocr\/bqaa011","article-title":"Reduced expression of the co-regulator TLE1 in type 2 diabetes is associated with increased islet \u03b1-cell number","volume":"161","author":"Armour","year":"2020","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0235","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ajt.14521","article-title":"Loss of end-differentiated \u03b2-cell phenotype following pancreatic islet transplantation","volume":"18","author":"Anderson","year":"2018","journal-title":"Am. J. Transp."},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3727\/096368908786092775","article-title":"Combination therapy with glucagon-like peptide-1 and gastrin induces \u03b2-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice","volume":"17","author":"Suarez-Pinzon","year":"2008","journal-title":"Cell Transp."},{"issue":"14","key":"10.1016\/j.bcp.2020.114216_b0245","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1073\/pnas.97.14.7999","article-title":"In vitro cultivation of human islets from expanded ductal tissue","volume":"97","author":"Bonner-Weir","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"48","key":"10.1016\/j.bcp.2020.114216_b0250","doi-asserted-by":"crossref","first-page":"33509","DOI":"10.1074\/jbc.M109.017608","article-title":"Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process","volume":"284","author":"Aviv","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2020.114216_b0255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/hmg\/ddm325","article-title":"The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1","volume":"17","author":"Brun","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2020.114216_b0260","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/db16-1009","article-title":"Glucagon-like peptide 1 protects pancreatic \u03b2-cells from death by increasing autophagic flux and restoring lysosomal function","volume":"66","author":"Zummo","year":"2017","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2020.114216_b0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clpt.2005.09.002","article-title":"Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses","volume":"78","author":"Herman","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2020.114216_b0270","unstructured":"FARXIGA- dapagliflozin tablet, film coated, https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=72ad22ae-efe6-4cd6-a302-98aaee423d69, (accessed 15\/05\/2020)."},{"issue":"3","key":"10.1016\/j.bcp.2020.114216_b0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/dmd.109.029165","article-title":"In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans","volume":"38","author":"Obermeier","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bcp.2020.114216_b0280","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/dom.12638","article-title":"Pharmacokinetics and pharmacodynamics of dapagliflozin in children and adolescents with type 2 diabetes mellitus","volume":"18","author":"Tirucherai","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"13","key":"10.1016\/j.bcp.2020.114216_b0285","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.celrep.2017.08.093","article-title":"Fumarate hydratase deletion in pancreatic beta cells leads to progressive diabetes","volume":"20","author":"Adam","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2020.114216_b0290","article-title":"Human islets contain a subpopulation of glucagon-like peptide-1 secreting \u03b1 cells that is increased in type 2 diabetes, Molecular","author":"Campbell","year":"2020","journal-title":"Metabolism"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:13:43Z","timestamp":1757769223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220304524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":58,"alternative-id":["S0006295220304524"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114216","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.03.234070","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic \u03b1-cell transdifferentiation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114216"}}